HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the target of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 41,800 shares, a growth of 42.7% from the July 15th total of 29,300 shares. Based on an average daily volume of 78,500 shares, the short-interest ratio is currently 0.5 days.
HAVN Life Sciences Stock Performance
OTCMKTS:HAVLF traded up $0.08 during mid-day trading on Friday, hitting $0.87. 711 shares of the company traded hands, compared to its average volume of 80,966. HAVN Life Sciences has a one year low of $0.03 and a one year high of $0.34. The stock's fifty day moving average price is $1.21 and its 200-day moving average price is $1.73.
Get HAVN Life Sciences alerts:About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Read More
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.